Cargando…
Time-in-range as a target in type 2 diabetes: An urgent need
Time-in-range emerged as a valuable blood glucose metric, ‘beyond HbA1c’ for a deeper insight into glycemic control in people with diabetes. It denotes the proportion of time that a person's glucose level remains within the desired target range (usually 70–180 mg/dL or 3.9–10.0 mmol/L). Though...
Autores principales: | Saboo, Banshi, Kesavadev, Jothydev, Shankar, Arun, Krishna, Meera B., Sheth, Shruti, Patel, Vidisha, Krishnan, Gopika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814148/ https://www.ncbi.nlm.nih.gov/pubmed/33506132 http://dx.doi.org/10.1016/j.heliyon.2021.e05967 |
Ejemplares similares
-
Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
por: Kesavadev, Jothydev, et al.
Publicado: (2015) -
Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas
por: Kesavadev, Jothydev, et al.
Publicado: (2020) -
The Do-It-Yourself Artificial Pancreas: A Comprehensive Review
por: Kesavadev, Jothydev, et al.
Publicado: (2020) -
Liraglutide therapy beyond glycemic control: an observational study in Indian patients with type 2 diabetes in real world setting
por: Kesavadev, Jothydev, et al.
Publicado: (2012) -
Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)
por: Kesavadev, Jothydev, et al.
Publicado: (2017)